Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | VHL |
| Variant | T202* |
| Impact List | nonsense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | VHL T202* results in a premature truncation of the Vhl protein at amino acid 202 of 213 (UniProt.org). T202* results in reduced Hif1a binding in low salt conditions and decreased Hif1a ubiquitination efficiency, and leads to increased Hif1a and Glut1 expression levels under hypoxic conditions in cell culture (PMID: 14691445). |
| Associated Drug Resistance | |
| Category Variants Paths |
VHL mutant VHL inact mut VHL T202* |
| Transcript | NM_000551.4 |
| gDNA | chr3:g.10149927_10149928delACinsTA |
| cDNA | c.604_605delACinsTA |
| Protein | p.T202* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000551.4 | chr3:g.10149927_10149928delACinsTA | c.604_605delACinsTA | p.T202* | RefSeq | GRCh38/hg38 |
| NM_000551.3 | chr3:g.10149927_10149928delACinsTA | c.604_605delACinsTA | p.T202* | RefSeq | GRCh38/hg38 |
| NM_000551 | chr3:g.10149927_10149928delACinsTA | c.604_605delACinsTA | p.T202* | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|